Carolyn Y. Johnson
Carolyn Y. Johnson
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
Pfizer reports encouraging early coronavirus vaccine data

Pfizer reports encouraging early coronavirus vaccine data

This article was published more than 2 years agoCommentGift ShareAn experimental coronavirus vaccine being developed by pharmaceutical giant and the German firm BioNTech triggered stronger immune responses in recipients than those seen in people naturally recovering from an infection in a small study .The work has not yet been peer-reviewed, and it is still unclear what level of immune response will protect a person from getting sick. But outside scientists praised the company for publishing the data on 45 people, and said the results support moving to a larger clinical trial to test...

July 1, 2020
Share
Save
Review
No Rating
Can old vaccines from science’s medicine cabinet ward off coronavirus?

Can old vaccines from science’s medicine cabinet ward off coronavirus?

This article was published more than 2 years agoCommentGift ShareTwo tried-and-true vaccines — a century-old inoculation against tuberculosis and a decades-old polio vaccine once given as a sugar cube — are being evaluated to see if they can offer limited protection against the coronavirus.Tests are already underway to see if the TB vaccine can slow the novel coronavirus, while other researchers writing in a scientific journal Thursday propose using the polio vaccine, which once was melted on children’s tongues.The old vaccines are oddities among the cutting-edge and targeted...

June 11, 2020
Share
Save
Review
No Rating
The biggest challenge for a coronavirus vaccine could be getting countries to share

The biggest challenge for a coronavirus vaccine could be getting countries to share

This article was published more than 2 years agoCommentGift ShareGlobal leaders came together Thursday to raise at least $2 billion toward providing a future vaccine for the novel coronavirus to people throughout the world — a precarious diplomatic endeavor and one of the biggest unresolved problems in using a vaccine to combat the pandemic.The virtual summit was convened by a public-private partnership called Gavi, which aims to increase vaccination rates in lower-income countries. At the summit, Gavi unveiled a proposal to ensure poor- and middle-income countries have access to the...

June 4, 2020
Share
Save
Review
No Rating
Trump pushing officials to speed up already-ambitious coronavirus vaccine timeline

Trump pushing officials to speed up already-ambitious coronavirus vaccine timeline

This article was published more than 2 years agoCommentGift SharePresident Trump, faced with multiple crises and falling poll numbers less than five months before the presidential election, is prodding top health officials to move faster on a by year’s end.The goal is to instill confidence among voters that the under Trump’s stewardship.In a meeting last month with Health and Human Services Secretary Alex Azar — who is overseeing the effort , along with Defense Secretary Mark T. Esper — Trump pushed Azar repeatedly to speed up the already unprecedented timeline, according to two senior...

June 17, 2020
Share
Save
Review
No Rating
Coronavirus may never go away, even with a vaccine

Coronavirus may never go away, even with a vaccine

This article was published more than 2 years agoCommentGift ShareThere’s a good chance the coronavirus will never go away.Even after a vaccine is discovered and deployed, the coronavirus will likely remain for decades to come, circulating among the world’s population.Experts call such diseases endemic — stubbornly resisting efforts to stamp them out. Think , , .It is a daunting proposition — a coronavirus-tinged world without a foreseeable end. But experts in epidemiology, disaster planning and vaccine development say embracing that reality is crucial to the next phase of America’s...

May 27, 2020
Share
Save
Review
No Rating
FDA pulls emergency approval for antimalarial drugs touted by Trump as covid-19 treatment

FDA pulls emergency approval for antimalarial drugs touted by Trump as covid-19 treatment

This article was published more than 2 years agoCommentGift ShareThe Food and Drug Administration withdrew its emergency use authorization for hydroxychloroquine and chloroquine, drugs that President Trump repeatedly promoted for treatment of covid-19, reversing a decision that led to harsh criticism it had put politics ahead of science.The FDA said Monday the medications “were unlikely to be effective” for covid-19 and that any potential benefits were outweighed by safety risks, including heart problems. The decision was from Denise Hinton, the agency’s chief scientist, to Gary...

June 15, 2020
Share
Save
Review
No Rating
The global race for a coronavirus vaccine could lead to this generation’s Sputnik moment

The global race for a coronavirus vaccine could lead to this generation’s Sputnik moment

This article was published more than 2 years agoCommentGift ShareWith testing underway on five experimental vaccines in China and four in the United States, the race to produce a vaccine for covid-19 has taken on political dimensions that echo jockeying for technological dominance during the Cold War, including the space race after the launch of Sputnik in 1957.The same day in mid-March that the United States of its first experimental , scientists in China announced their own trial would begin. Days after a company from the first U.S. human tests last month, a of the Chinese trial was...

June 3, 2020
Share
Save
Review
No Rating
States rushing to reopen are likely making a deadly error, coronavirus models and experts warn

States rushing to reopen are likely making a deadly error, coronavirus models and experts warn

This article was published more than 2 years agoCommentGift ShareBy the end of the week, will be able to get their hair permed and nails done. By Monday, they will be cleared for action flicks at the cineplex and burgers at their favorite greasy spoon.And it will almost certainly lead to more novel coronavirus infections and deaths.As several states — including South Carolina, Tennessee and Florida — rush to reopen businesses, the sudden relaxation of restrictions will supply new targets for the coronavirus that has kept the United States largely closed down, according to experts, math...

April 22, 2020
Share
Save
Review
No Rating
Trump sets goal of hundreds of millions of coronavirus vaccine doses by January, but scientists doubt it

Trump sets goal of hundreds of millions of coronavirus vaccine doses by January, but scientists doubt it

This article was published more than 2 years agoCommentGift ShareThis article is free to access.Why?The Washington Post is providing this news free to all readers as a public service.Follow this story and more by President Trump formally unveiled an initiative Friday afternoon aimed at making hundreds of millions of doses of a broadly available by year’s end — a goal that many scientists say is unrealistic and could even backfire by shortchanging safety and more broadly.The Rose Garden news conference added to a week of confusing and contradictory remarks about the prospects and...

May 15, 2020
Share
Save
Review
No Rating
Inexpensive steroid dexamethasone is the first drug to reduce deaths from covid-19

Inexpensive steroid dexamethasone is the first drug to reduce deaths from covid-19

This article was published more than 2 years agoCommentGift ShareThis article is free to access.Why?The Washington Post is providing this news free to all readers as a public service.Follow this story and more by LONDON — An inexpensive steroid reduced deaths from coronavirus infection, helping some of the sickest patients with severe lung damage survive the illness, according to British clinical trial results announced Tuesday in a news release.The 60-year-old drug, dexamethasone, is the first medication shown to increase people’s chances of surviving covid-19, the disease caused by...

June 16, 2020
Share
Save
Review
OUTLETS
washingtonpost.com

washingtonpost.com

CRITIC
img-trusted
88%
PUBLIC
img-trusted
68%
adn.com

adn.com

CRITIC
img-contested
N/A
PUBLIC
img-trusted
100%